Document is current

Any future updates will be listed below

Risk of ophthalmic adverse drug reactions in patients prescribed glucagon-like peptide 1 receptor agonists: a pharmacovigilance study based on the FDA adverse event reporting system database

Crossref DOI link: https://doi.org/10.1007/s12020-024-04112-8

Published Online: 2024-11-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark